DUSP28 and familial pancreatic carcinoma: Our results demonstrate that DUSP28 plays a key role in the drug-resistance and migratory activity in human pancreatic cancer cells through the ERK pathway, suggesting that targeting DUSP28 might be a challenging strategy for patients with pancreatic cancer.